| Ameliorating effect of rutin against diclofenac-induced cardiac injury in rats with underlying function of FABP3, MYL3, and ANP A Dogra, D Kour, A Gour, M Bhardwaj, S Bag, SK Dhiman, A Kumar, ... Drug and Chemical Toxicology 46 (3), 597-608, 2023 | 10 | 2023 |
| Glabridin plays dual action to augment the efficacy and attenuate the hepatotoxicity of methotrexate in arthritic rats A Dogra, D Kour, M Bhardwaj, S Dhiman, A Kumar, B Vij, A Kumar, ... ACS omega 7 (38), 34341-34351, 2022 | 10 | 2022 |
| Sila-CBD Derivatives as Inhibitors of Heme-Induced NLRP3 Inflammasome: Application in Hemolytic Diseases SS Shete, F Iqbal, M Bhardwaj, U Nandi, A Kumar, DS Reddy ACS Medicinal Chemistry Letters 14 (12), 1716-1723, 2023 | 4 | 2023 |
| Orally bioavailable styryl derivative of rohitukine-N-oxide inhibits CDK9/T1 and the growth of pancreatic cancer cells D Bhurta, MM Hossain, M Bhardwaj, F Showket, U Nandi, MJ Dar, ... European Journal of Medicinal Chemistry 258, 115533, 2023 | 4 | 2023 |
| Ayurveda-based phytochemical composition attenuates lung inflammation and precipitates pharmacokinetic interaction with favipiravir: an in vivo investigation … A Gour, A Dogra, MK Verma, M Bhardwaj, D Kour, A Jamwal, B Gorain, ... Natural Product Research 37 (22), 3758-3765, 2023 | 2 | 2023 |
| Impact of Disease States on the Oral Pharmacokinetics of EIDD-1931 (an Active Form of Molnupiravir) in Rats for Implication in the Dose Adjustment M Bhardwaj, A Gour, A Ahmed, S Dhiman, D Manhas, P Khajuria, P Wazir, ... Molecular Pharmaceutics 20 (9), 4597-4610, 2023 | 2 | 2023 |
| Ellagic Acid Exerts Dual Action to Curb the Pathophysiological Manifestations of Sickle Cell Disease and Attenuate the Hydroxyurea-Induced Myelosuppression in Berkeley Mice A Gour, D Kour, R Pandian, M Bhardwaj, SD Sawant, A Kumar, U Nandi ACS Pharmacology & Translational Science 6 (6), 868-877, 2023 | 2 | 2023 |
| A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy N Sakander, A Ahmed, M Bhardwaj, D Kumari, U Nandi, D Mukherjee Bioorganic Chemistry, 107379, 2024 | 1 | 2024 |
| Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner MO Ayaz, AQ Bhat, Z Akhter, N Badsera, MM Hossain, F Showket, ... Life Sciences 351, 122840, 2024 | | 2024 |
| EIDD-1931 Treatment Tweaks CYP3A4 and CYP2C8 in Arthritic Rats to Expedite Drug Interaction: Implication in Oral Therapy of Molnupiravir M Bhardwaj, D Kour, G Rai, S Bhattacharya, D Manhas, B Vij, A Kumar, ... ACS omega 9 (12), 13982-13993, 2024 | | 2024 |
